EarningsQ2 2026 Earnings Report

Nu Skin (NUS) Q2 2026 Earnings Report

1 Followers

Previous Report: Q1 2026

MX:NUS Q2 2026 EPS Results

Actual EPS$3.41

Consensus EPS$3.41

Beat/MissMet expectations

One Year Ago EPS$7.34

MX:NUS Q2 2026 Revenue Results

Actual Revenue$5.46B

Expected Revenue$5.89B

Beat/MissMissed by -$428.20M

YoY Revenue Growth-17.10%

Earnings Announcement Details

QuarterQ2 2026

Date08/10/2026

TimeAfter Close

Conference CallMonday, August 10, 2026

MX:NUS Upcoming Earnings

Nu Skin's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:NUS Q2 2026 Earnings Call

0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026

Earnings Call Date:Aug 10, 2026|

% Change Since:

Earnings Call Sentiment|Neutral

The call presented a mixed picture: strong product momentum and engagement around Prysm iO, improved core gross margin, cost reductions in G&A, and disciplined liquidity position are notable positives. However, sizable non-cash goodwill and deferred tax charges materially impacted reported earnings, adjusted operating margins declined, recruiting and leadership development remain weak, and the India launch was delayed. Near-term FX headwinds and modest operating cash flow further temper the outlook. On balance, the company shows encouraging strategic traction and product adoption but faces meaningful near-term financial and operational headwinds.

Company Guidance

Nu Skin updated Q3 revenue guidance to $310–$340 million (with an expected 2–3% foreign currency headwind) and Q3 EPS of $0.00–$0.09 reported (adjusted $0.10–$0.20), and revised full‑year revenue to $1.28–$1.35 billion (≈1% FX headwind) with reported FY EPS of −$4.90 to −$4.73 (adjusted $0.70–$0.90) and an adjusted effective tax rate of ~35%; management expects to place 50,000–60,000 Prysm iO devices by year‑end (vs. >39,000 placed to date, up ~30% QoQ, and 2.5 million scans, up ~25% QoQ). The company plans $5–$10 million of cash‑based organizational transition costs through year‑end excluded from adjusted results and also excluded the Q2 non‑cash charges (a $78.9M goodwill impairment and a $167.5M deferred tax valuation allowance) from adjusted guidance; for context Q2 revenue was $320.1M, gross margin 68.2% (core 77.7%), adjusted operating margin 6.1%, cash $189.6M, debt $213.7M and Q2 operating cash flow $10.6M.

Quarterly Revenue

Q2 2026 revenue of $320.1 million (includes ~1% / $4M FX headwind). Full-year revenue guidance updated to $1.28–$1.35 billion (FY FX headwind ~1%).

Prysm iO Adoption and Engagement

More than 39,000 Prysm iO devices placed to date (up nearly 30% quarter-over-quarter) and ~2.5 million scans (up ~25% QoQ). Company expects 50,000–60,000 devices by year-end and will introduce an AI-enabled Prysm iO app to boost personalization, engagement, conversion and lifetime value.

Core Gross Margin Improvement

Core Nu Skin gross margin improved to 77.7%, up 20 basis points year-over-year, reflecting progress on margin improvement initiatives.

Adjusted EPS and Guidance

Adjusted EPS for Q2 was in line with prior guidance (company reiterates adjusted full-year EPS guidance of $0.70–$0.90). Q3 adjusted EPS guidance of $0.10–$0.20 and Q3 revenue guidance of $310–$340 million (anticipating 2–3% FX headwind).

Cost Discipline and G&A Reduction

General & administrative expenses declined by $15.9 million year-over-year, demonstrating continued cost discipline while investing in strategic priorities.

Balance Sheet and Liquidity

Generated $10.6 million of operating cash flow in the quarter; ended Q2 with $189.6 million in cash and cash equivalents. Total debt was $213.7 million and $137.3 million remained available under the share repurchase authorization.

Strategic Operating Changes

Announced an East-West operating model to increase agility and efficiency (transition over next two quarters) and a revised global compensation/leadership roadmap to strengthen recruiting and leadership development.

MX:NUS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	3.58 / -	5.803	―
Aug 10, 2026	2026 (Q2)	3.41 / 3.41	7.339	-53.49% (-3.93)
May 07, 2026	2026 (Q1)	2.56 / 2.39	3.926	-39.13% (-1.54)
Feb 12, 2026	2025 (Q4)	5.12 / 4.95	6.486	-23.68% (-1.54)
Nov 06, 2025	2025 (Q3)	5.12 / 5.80	2.902	100.00% (+2.90)
Aug 07, 2025	2025 (Q2)	- / 7.34	3.584	104.76% (+3.75)
May 08, 2025	2025 (Q1)	2.24 / 3.93	1.536	155.56% (+2.39)
Feb 13, 2025	2024 (Q4)	3.67 / 6.49	6.315	2.70% (+0.17)
Nov 07, 2024	2024 (Q3)	3.36 / 2.90	-12.63	122.97% (+15.53)
Aug 08, 2024	2024 (Q2)	2.85 / 3.58	9.217	-61.11% (-5.63)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed